Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
December 31, 2003
Warfarin prophylaxis in the antiphospholipid antibody syndrome
Christoph M Kosinski
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 2003
Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
Christian Prueter, Benedikt Habermeyer, Christine Norra, et al.
Lancet (London, England)
|
October 19, 2004
Eyelid oedema and headache
Roland Sparing, Christoph M Kosinski, Timo Krings, et al.
Journal of Neurology
|
September 30, 2008
High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. Medium-term follow-up
Judith U Harrer, Ralf Morschel, Michael Mull, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 6, 2008
Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis
Manuel Dafotakis, Roland Sparing, Agnes Juzek, et al.
The Journal of Gene Medicine
|
December 11, 2007
Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion
Bin Huang, Johannes Schiefer, Christian Sass, et al.
Neuroscience Letters
|
November 19, 2002
Huntington's disease transgenic mice are resistant to global cerebral ischemia
Johannes Schiefer, Anke Alberty, Tatjana Dose, et al.
Human Gene Therapy
|
May 3, 2007
High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo
Bin Huang, Johannes Schiefer, Christian Sass, et al.
Nuclear Medicine and Biology
|
July 1, 2008
Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice
Philipp T Meyer, Dagmar Salber, Johannes Schiefer, et al.
Brain Research
|
August 13, 2004
The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease
Johannes Schiefer, Arne Sprünken, Christiane Puls, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
December 31, 2003
Warfarin prophylaxis in the antiphospholipid antibody syndrome
Christoph M Kosinski
Movement Disorders : Official Journal of the Movement Disorder Society
|
June 5, 2003
Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease
Christian Prueter, Benedikt Habermeyer, Christine Norra, et al.
Lancet (London, England)
|
October 19, 2004
Eyelid oedema and headache
Roland Sparing, Christoph M Kosinski, Timo Krings, et al.
Journal of Neurology
|
September 30, 2008
High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. Medium-term follow-up
Judith U Harrer, Ralf Morschel, Michael Mull, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 6, 2008
Transdermal dopaminergic stimulation with rotigotine in Parkinsonian akinetic crisis
Manuel Dafotakis, Roland Sparing, Agnes Juzek, et al.
The Journal of Gene Medicine
|
December 11, 2007
Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion
Bin Huang, Johannes Schiefer, Christian Sass, et al.
Neuroscience Letters
|
November 19, 2002
Huntington's disease transgenic mice are resistant to global cerebral ischemia
Johannes Schiefer, Anke Alberty, Tatjana Dose, et al.
Human Gene Therapy
|
May 3, 2007
High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo
Bin Huang, Johannes Schiefer, Christian Sass, et al.
Nuclear Medicine and Biology
|
July 1, 2008
Comparison of intravenous and intraperitoneal [123I]IBZM injection for dopamine D2 receptor imaging in mice
Philipp T Meyer, Dagmar Salber, Johannes Schiefer, et al.
Brain Research
|
August 13, 2004
The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease
Johannes Schiefer, Arne Sprünken, Christiane Puls, et al.
Page
of 2